Answers are grounded in this paper and cite their sources.
Experimental analysis shows alleviation of inflammation and apoptosis in HK-2 cells, suggesting circRNA modulation as a therapeutic strategy for AKI.
Circular RNA (circRNA) has been confirmed to be a regulator for septic acute kidney injury (AKI). It is reported that circ_0049271 has abnormal expression in AKI patients, but its role and mechanism in septic AKI remain unclear. Lipopolysaccharide (LPS)-stimulated HK-2 cells were served as the cellular model of sepsis-associated AKI (SAKI). qRT-PCR was conducted for examining the expression of circ_0049271, KEAP1 and miR-331-3p. Cell proliferation and apoptosis were detected by EdU assay and flow cytometry. The protein levels of apoptosis-related markers, RUNX family transcription factor 1 (RUNX1), and PI3K/AKT/mTOR pathway-related markers were tested using Western blot. RNA interaction was confirmed by dual-luciferase reporter assay, RIP assay, and RNA pull-down assay. Our data showed that circ_0049271 was enhanced in LPS-induced HK-2 cells. Silencing of circ_0049271 attenuated LPS-induced HK-2 cell oxidative stress, apoptosis, and inflammation. In terms of mechanism, circ_0049271 targeted miR-331-3p to promote LPS-induced HK-2 cell injury. RUNX1 was a target of miR-331-3p, and RUNX1 overexpression reversed miR-331-3p-mediated inhibitory effects on LPS-induced HK-2 cell injury. Moreover, circ_0049271 sponged miR-331-3p to positively regulate RUNX1 expression, thus activating the PI3K/AKT/mTOR pathway. In conclusion, our data indicated that circ_0049271 contributed to LPS-induced HK-2 cell injury by regulating miR-331-3p/RUNX1 pathway, providing potential molecular targets for the treatment of SAKI.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: